^
BIOMARKER:

CEBPA mutation

i
Other names: CEBPA, CCAAT Enhancer Binding Protein Alpha, CCAAT/Enhancer Binding Protein (C/EBP), Alpha, CCAAT/Enhancer-Binding Protein Alpha, CEBP, CCAAT/Enhancer Binding Protein Alpha, C/EBP-Alpha, C/EBP Alpha
Entrez ID:
CEBPA mutation
AML
cytarabine/daunorubicin liposomal formulation
Sensitive: C2 – Inclusion Criteria
CEBPA mutation
AML
quizartinib
Sensitive: C3 – Early Trials
CEBPA mutation
AML
venetoclax
Sensitive: C3 – Early Trials
CEBPA mutation
AML
cytarabine
Sensitive: C4 – Case Studies
CEBPA mutation
AML
venetoclax + IACS-010759
Sensitive: D – Preclinical
CEBPA mutation
AML
OICR-9429
Sensitive: D – Preclinical